Experts estimate that anywhere from 24% to 90% of women experience low back or pelvic-region pain when they are pregnant. Many women find that this pain goes away when the baby is born. However, more than a third of women still have pain 1 year after giving birth. Physical therapy during and after pregnancy can help decrease low back and pelvic pain. Common treatment options include education, exercise therapy, manual therapy, braces, or a combination of these treatments. Learning new ways to per
form home and work activities as well as relaxation techniques can help ease the pain. A study published in the July 2014
issu eof JOSPT reviewed the best published research to better understand the benefits of physical therapy in treating women with back and pelvic pain during and after pregnancy
Read More:
Pregnancy and Physical Therapy
Physical therapy during pregnancy can be useful for remedying common discomforts like back pain or for enhancing your body’s ability to have a smoother pregnancy and birth. Physical therapy is not just for recovery. Talk to your health care provider about incorporating physical therapy into your prenatal care.
The reasons for back pain vary from person to person, but the majority of back pain concerns can be accounted for by one of the following reasons:
- an increase in hormones
- a change in the body’s center of gravity
- gaining additional weight
- a decline in posture
- added stress
Over the last 40 years, the average age of women having their first child has risen from 21.4 to 25 years of age. Due to the fact that many women are juggling both the demands of pursuing higher education and the competitive nature of today’s workforce, more women are having their first child after the age of thirty five.
American College of Rheumatology Praises Congressional Leaders for Passing Spending Bill that Includes Part B Fix, Therapy Caps Repeal
Washington, DC, Feb. 09, 2018 (GLOBE NEWSWIRE) — The American College of Rheumatology praises Congressional leaders for passing today’s sweeping spending agreement, which includes a technical provision reversing a Centers for Medicare & Medicaid Services (CMS) policy that would have linked physicians’ quality payment adjustments to Medicare Part B drug costs starting in 2019. The ACR also applauded the inclusion of provisions that permanently repeal Medicare caps on outpatient therapies and other rehabilitation services, repeal the Independent Payment Advisory Board (IPAB), and eliminate the Medicare Part D donut hole.
“The healthcare provisions included in today’s spending agreement are a huge victory for the more than 54 million Americans living with rheumatic diseases, many of whom rely on biologic therapies and vital rehabilitation services to manage their disease,” said ACR President David Daikh, MD, PhD. “We thank Congressional leaders for coming together swiftly and in a bipartisan fashion to ensure that Americans living with diseases like rheumatoid arthritis can access the infusion therapies and rehabilitation services that help them avoid disability and maintain quality of life. This victory would not have been possible without the efforts of the many rheumatologists and rheumatology health professionals throughout the nation who voiced their concerns to lawmakers and brought attention to these incredibly important issues.”
The Part B technical correction in the spending bill comes after the ACR and more than 100 other healthcare groups urged Congressional leaders to step in and reverse course on a CMS policy that would have created extreme financial volatility for specialists who administer Part B drugs and made it more difficult for patients – particularly those living in rural and underserved areas of the country – to access physician-administered infusion therapies.
According to an analysis from Avalere Health, certain specialists who administer Part B drugs – including rheumatologists, oncologists and ophthalmologists – would have seen payment cuts as high as 29 percent under the CMS policy to factor Part B drugs in MIPS payment calculations, compromising the ability of some providers to continue administering complex infusion therapies in the office setting.